Serotonin, dopamine and norepinephrine transporters in the central nervous system and their inhibitors
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
An overview is presented on progress made in the research on neuronal transporters of serotonin, dopamine and norepinephrine in the central nervous system. Tools developed by molecular biology, such as expression of cloned transporters, their mutants and chimera in non-neuronal cells offered the opportunity to study the putative domains for binding of substrates and uptake inhibitors and discover factors in the regulation of the transporter function. The study of the distribution of monoamine transporters in human brain became possible by the development of selective radiolabelled transport inhibitors. The relationships between the chemical structure of the uptake inhibitors and the affinity for the monoamine transporters is reported, and the (potential) therapeutic applications of the compounds are discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pharmacological profile of antidepressants and related compounds at human monoamine transporters
Tatsumi, M., Groshan, K., Blakely, R. D., & Richelson, E. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01393-9 · Cited by 939
Expression cloning of a cocaine-and antidepressant-sensitive human noradrenaline transporter
Pacholczyk, T., Blakely, R. D., & Amara, S. G. (1991) · Nature · doi:10.1038/350350a0 · Cited by 933
Neurotransmitter Receptor and Transporter Binding Profile of Antidepressants and Their Metabolites
Owens, M. J., Morgan, W. N., Plott, S. J., & Nemeroff, C. B. (1997) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37161-7 · Cited by 676
Pharmacological characterization of selective serotonin reuptake inhibitors (SSRIs)
Hyttel, J. (1994) · International Clinical Psychopharmacology · doi:10.1097/00004850-199403001-00004 · Cited by 492
Cited by
Millan, M. J. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.11.006 · Cited by 551
Chen, N.-H., Reith, M. E. A., & Quick, M. W. (2004) · Pfl�gers Archiv European Journal of Physiology · doi:10.1007/s00424-003-1064-5 · Cited by 409
LeuT-Desipramine Structure Reveals How Antidepressants Block Neurotransmitter Reuptake
Zhou, Z., Zhen, J., Karpowich, N. K., Goetz, R. M., Law, C. J., Reith, M. E. A., & Wang, D.-N. (2007) · Science · doi:10.1126/science.1147614 · Cited by 333
Serotonin: A never-ending story
Olivier, B. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.10.031 · Cited by 253
“Dapoxetine is a SERT inhibitor of the aryloxypropanamine type where also fluoxetine and paroxetine belong too (Olivier et al., 2000).”
BackgroundSelf-citationSerotonin and dopamine transporter imaging in patients with obsessive-compulsive disorder
Hesse, S., Müller, U., Lincke, T., Barthel, H., Villmann, T., Angermeyer, M. C., Sabri, O., & Stengler-Wenzke, K. (2005) · Psychiatry Research: Neuroimaging · doi:10.1016/j.pscychresns.2005.07.002 · Cited by 155
“The striatum, which is known to have a high density of DAT, and the SERTrich brain regions of the thalamus/hypothalamus, midbrain, and upper brainstem, respectively, were delineated as well as the occipital cortex, which served as the reference ROI (non-specific bound and free radioactivity) because of its low SERT an…”
BackgroundInfluential
Metadata
- Authors
- Olivier, B., Soudijn, W., & van Wijngaarden, I.
- Venue
- Progress in Drug Research
- Publisher
- Birkhäuser Basel
- Published
- 2000
- Volume
- 54
- Pages
- 59-119
- OpenAlex
- W2214928936
- Cited by
- 69
- References
- 4
- FWCI
- 4.27
- Type
- book chapter
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Serotonin, dopamine and norepinephrine transporters in the central nervous system and their inhibitors. https://app.cochat.ai/papers/10.1007/978-3-0348-8391-7_3
- The paper
- Olivier, B., Soudijn, W., & van Wijngaarden, I. (2000). Serotonin, dopamine and norepinephrine transporters in the central nervous system and their inhibitors. Progress in Drug Research. https://doi.org/10.1007/978-3-0348-8391-7_3
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.